Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01801384 · ClinicalTrials.gov registry record · NA

Voucher Based Incentives to Treat Pregnant Smokers

A NA study, sponsored by University of Vermont.

Completed
Registry status
NA
Development phase
166
Enrollment target

NCT01801384: Completed NA study, sponsored by University of Vermont.

NCT01801384 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 166 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01801384, a NA study, has completed, sponsored by University of Vermont.

COMPLETED
Registry status
NA
Development phase
166 participants
Enrollment target

Study Summary

The major goal of this project is to examine the efficacy of a voucher-based incentive program for promoting smoking cessation (Study 1) and preventing relapse (Study 2) during pregnancy and postpartum. Identifying efficacious interventions to increase cessation rates and decrease relapse among those who are able to quit is important to improving U.S. public health.

Interventions

  • BEHAVIORAL Voucher-based incentives

Trial Details

FieldValue
Enrollment Target 166 participants
Start Date 2006-04
Est. Completion 2011-05
Phase NA
University of Vermont

162 total trials

What the finished NCT01801384 record still lists

NCT01801384 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 1 intervention - of which Voucher-based incentives is the first listed.

NCT01801384 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01801384 about?

NCT01801384 is a clinical study titled "Voucher Based Incentives to Treat Pregnant Smokers". The major goal of this project is to examine the efficacy of a voucher-based incentive program for promoting smoking cessation (Study 1) and preventing relapse (Study 2) during pregnancy and postpartum. Identifying efficacious interventions to increase cessation rates and decrease relapse among thos...

What is the current status of trial NCT01801384?

This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2006-04. Estimated completion is 2011-05.

What interventions are being tested in trial NCT01801384?

The interventions under investigation include: Voucher-based incentives (BEHAVIORAL).

Who is sponsoring clinical trial NCT01801384?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01801384's enrollment target sits among peer trials

166 625th of 2000 higher than 1,375 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02747303 · 166 participants · Phase 2

    Frameless Stereotactic Radiosurgery for Intact Brain Metastases

  • NCT03806283 · 166 participants

    Mechanisms of Pregnancy Vascular Adaptations

  • NCT04040452 · 166 participants · Phase 4

    Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery

  • NCT04375813 · 166 participants · Phase 2

    Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01801384, the US trial registry maintained by the National Library of Medicine. NCT01801384 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.